Methanesulfonic Acid → HCID 86746537, 화합물
반응식
[F:1][C:2]1[CH:3]=[C:4]2[C:9]3=[C:10]([CH2:19][C@H:20]([CH3:21])[N:8]3[CH:7]=[C:6]([C:22]([OH:24])=[O:23])[C:5]2=[O:25])[C:11]=1[N:12]1[CH2:17][CH2:16][NH:15][CH:14]([CH3:18])[CH2:13]1.[CH3:26][S:27]([OH:30])(=[O:29])=[O:28]>>[CH3:26][S:27]([OH:30])(=[O:29])=[O:28].[F:1][C:2]1[CH:3]=[C:4]2[C:9]3=[C:10]([CH2:19][C@H:20]([CH3:21])[N:8]3[CH:7]=[C:6]([C:22]([OH:24])=[O:23])[C:5]2=[O:25])[C:11]=1[N:12]1[CH2:17][CH2:16][NH:15][CH:14]([CH3:18])[CH2:13]1참가 물질
3
실험 절차
(+)-8-fluoro-2-(S)-methyl-9-(3-methyl-1-piperazinyl)-6-oxo-1,2-dihydro-6H-pyrrolo[3,2,1-ij]quinoline-5-carboxylic acid and methanesulfonic acid were used, and treated in a manner analogous to Example 21, to give the title compound.
후처리
- additiontreated in a manner analogous to Example 21
출처 및 근거
- ORD 기록
- ord-53c5f25db787484e8ca58115c1e6fee3